Open AccessA comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma
Author(s) -
Simon Portsmouth,
Justin Stebbing,
Jas Gill,
Sundhiya Mandalia,
Mark Bower,
Mark Nelson,
Brian Gazzard
Publication year - 2003
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200307250-00001
Subject(s) - medicine , incidence (geometry) , reverse transcriptase inhibitor , confidence interval , prospective cohort study , gastroenterology , cohort study , viral load , sida , immunology , viral disease , human immunodeficiency virus (hiv) , physics , optics
To determine the incidence of Kaposi's sarcoma (KS) in a prospective longitudinal cohort of HIV-1-infected individuals before during and after the introduction of highly active antiretroviral therapy (HAART) and to compare the incidence of KS between specific HAART regimens.